CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Glenmark Pharmaceuticals Ltd.

NSE : GLENMARKEQ BSE : 532296 ISIN CODE : INE935A01035Industry : Pharmaceuticals

News

  • Glenmark Pharma. - General Updates 01 Apr 2026 | 19:09 | Dion Global

    Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Regulatory action/ inspectionmore...

  • Glenmark Pharma. - Press Release 01 Apr 2026 | 17:31 | Dion Global

    Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01 2026 titled Glenmark Pharmaceuticals Ann...more...

  • Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 01 Apr 2026 | 17:30 | Dion Global

    Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S. Significantly Expanding Its I...more...

  • Glenmark Pharma. - Press Release 19 Mar 2026 | 08:38 | Dion Global

    Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 19 2026 titled Glenmark Pharmaceuticals Inc...more...

  • Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 19 Mar 2026 | 08:37 | Dion Global

    Glenmark Pharmaceuticals Inc. USA launches Authorised Generic to Milnacipran Hydrochloride Tablets 12.5 mg 25 mg 50 mg and 100 mgmore...

  • Glenmark Pharma. - Press Release 19 Mar 2026 | 08:35 | Dion Global

    Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 19 2026 titled Glenmark Therapeutics Inc. U...more...

  • Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 19 Mar 2026 | 08:32 | Dion Global

    Glenmark Therapeutics Inc. USA launches Fluticasone Propionate Nasal Spray USP 50 mcg per spray (OTC)more...

  • Glenmark Pharma’s US arm to launch Potassium Phosphates Injection 16 Mar 2026 | 11:02 | Dion Global

    Glenmark Pharmaceuticals Inc. has announced the upcoming launch of Potassium Phosphates Injection USP in the United States in multiple vial ...more...

  • Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 16 Mar 2026 | 08:46 | Dion Global

    Glenmark Pharmaceuticals Inc. USA to launch Potassium Phospohates Injection USP 15 mmol P / 22 mEq K per 5 mL and 45 mmol P / 66 mEq K per 15 mL Sing...more...

  • Glenmark Pharma. - Press Release 16 Mar 2026 | 08:44 | Dion Global

    Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 16 2026 titled Glenmark Pharmaceuticals Inc...more...

  • Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 04 Mar 2026 | 08:38 | Dion Global

    Glenmark Specialty SA Receives U.S. FDA approval for Fluticasone Propionate Inhalation Aerosol USP 44 mcg per actuation with 180-Day Competitive Gene...more...

  • Glenmark Pharma. - Press Release 04 Mar 2026 | 08:37 | Dion Global

    Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 04 2026 titled Glenmark Specialty SA Receiv...more...

  • Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 27 Feb 2026 | 09:22 | Dion Global

    Glenmark Pharmaceuticals Inc. USA to launch Sodium Phosphates Injection USP 15 mM P/5 mL 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) Single - Dose V...more...

  • Glenmark Pharma. - Press Release 27 Feb 2026 | 09:20 | Dion Global

    Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 27 2026 titled Glenmark Pharmaceuticals ...more...

  • Glenmark Pharma. - General Updates 20 Feb 2026 | 17:30 | Dion Global

    Glenmark Pharmaceuticals Limited has informed the Exchange about ESG Rating.more...

  • Glenmark Pharma. - Announcement Under Regulation 30 Of The SEBI LODR 20 Feb 2026 | 17:30 | Dion Global

    Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - ESG Ratingsmore...

  • Glenmark Pharma. - Copy of Newspaper Publication 18 Feb 2026 | 16:27 | Dion Global

    Glenmark Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Glenmark Pharma. - Analysts/Institutional Investor Meet/Con. Call Updates 04 Feb 2026 | 15:20 | Dion Global

    Glenmark Pharmaceuticals Limited has informed the Exchange about Transcriptmore...

  • Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 04 Feb 2026 | 15:17 | Dion Global

    The transcript of the Earnings Call held on Monday February 02 2026 has been uploaded on the Company s website.more...

  • Glenmark Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 02 Feb 2026 | 16:39 | Dion Global

    Pursuant to the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform t...more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex73319.550.25%
NSE Index22713.10.14%
B500DIVL503403.970.30%
BSE 1000 9743.290.10%
BSE 100LCTMC8424.510.17%
BSE Auto 53233.86-0.65%

Commodity

Gold146091-2.67%
Silver227633-4.92%
Copper1195.4193.13%
Crude Oil947747.78%
Lead201.249.70%
Mentha Oil1116.54.60%
Nickel1650115.15%

Currency

USD/INR 94.65(0.05 %)
GBP/INR 125.63(-0.45 %)
EUR/INR 109.01(-0.13 %)
JPY/INR 0.59(-0.43 %)
CAD/INR 67.96(-0.14 %)
HKD/INR 12.08(-0.06 %)